文献速递头颈外科

二甲双胍对口腔鳞癌共注射异种移植瘤代谢偶联与生长的影响

Metformin Effects on Metabolic Coupling and Tumor Growth in Oral Cavity Squamous Cell Carcinoma Coinjection Xenografts.
PubMed 文献 · Otolaryngol Head Neck Surg · 2017-12-12

该研究在口腔鳞癌细胞与成纤维细胞共注射的小鼠异种移植瘤模型中,发现共注射肿瘤体积增大2.8倍且MCT1染色增强1.4倍;二甲双胍使共注射肿瘤缩小45%、MCT1染色降低28%、癌细胞凋亡增加1.8倍,但CAV1敲低成纤维细胞共注射时二甲双胍对肿瘤大小无显著影响。

要点

  • 成纤维细胞共注射促进口腔癌异种移植瘤生长和代谢偶联。
  • 二甲双胍可缩小共注射肿瘤并破坏代谢偶联、促进凋亡。
  • 成纤维细胞CAV1表达是二甲双胍发挥作用所必需的。

核心结论

  • 成纤维细胞共注射增加口腔癌异种移植瘤生长和代谢偶联。
  • 二甲双胍破坏代谢偶联并缩小肿瘤依赖成纤维细胞CAV1表达。

研究设计与样本

  • 研究设计为头颈鳞癌异种移植瘤模型,设置为基础科学实验室研究。
  • 口腔癌细胞单独或与人成纤维细胞共注射入裸鼠生成移植瘤。

主要发现

  • 共注射肿瘤体积为同型癌细胞注射肿瘤的2.8倍(P = .048)。
  • 共注射肿瘤MCT1染色强度为同型注射的1.4倍(P = .016)。
  • 二甲双胍使共注射肿瘤体积缩小45%(P = .025)。
  • 二甲双胍使MCT1染色降低28%(P = .05),TUNEL标记的癌细胞凋亡增加1.8倍(P = .005)。
  • CAV1敲低成纤维细胞共注射时,二甲双胍对肿瘤大小无显著影响。

关键数值与推荐

  • 共注射肿瘤体积较同型注射增大2.8倍(P = .048)。
  • 共注射肿瘤MCT1染色较同型注射增强1.4倍(P = .016)。
  • 二甲双胍使共注射肿瘤缩小45%(P = .025)。
  • 二甲双胍使MCT1染色降低28%(P = .05),凋亡增加1.8倍(P = .005)。

临床怎么用

  • 提示二甲双胍对口腔癌的作用可能依赖肿瘤微环境中成纤维细胞CAV1表达。
  • 为靶向肿瘤代谢偶联的治疗策略提供临床前依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective Many aggressive head and neck cancers contain 2 metabolically coupled tumor compartments: a glycolytic stromal compartment with low caveolin-1 (CAV1) and high monocarboxylate transporter 4 (MCT4) expression and a highly proliferative carcinoma cell compartment with high MCT1. Metabolites are shuttled by MCTs from stroma to carcinoma to fuel tumor growth. We studied the effect of carcinoma-fibroblast coinjection and metformin administration on a mouse model of head and neck squamous cell carcinoma. Study Design Xenograft head and neck squamous cell carcinoma model. Setting Basic science laboratory. Subjects and Methods Oral cavity carcinoma cells were injected alone or as coinjection with human fibroblasts into nude mice to generate xenograft tumors. Tumors were excised and stained with immunohistochemistry for markers of metabolic coupling and apoptosis, including MCT1, MCT4, CAV1, and TUNEL assay (terminal deoxynucleotidyl transferase nick end labeling). Strength of staining was assessed by a pathologist or computer-assisted pathology software. Metformin was administered orally to mice to test effects on immunohistochemical markers in xenografts. Results Coinjection tumors were 2.8-fold larger ( P = .048) and had 1.4-fold stronger MCT1 staining ( P = .016) than tumors from homotypic carcinoma cell injection. Metformin decreased the size of coinjection xenograft tumors by 45% ( P = .025). Metformin reduced MCT1 staining by 28% ( P = .05) and increased carcinoma cell apoptosis 1.8-fold as marked by TUNEL assay ( P = .005). Metformin did not have a significant effect on tumor size when CAV1 knockdown fibroblasts were used in coinjection. Conclusion Coinjection with fibroblasts increases tumor growth and metabolic coupling in oral cavity cancer xenografts. Fibroblast CAV1 expression is required for metformin to disrupt metabolic coupling and decrease xenograft size.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Tassone P, Domingo-Vidal M, Whitaker-Menezes D, et al. Metformin Effects on Metabolic Coupling and Tumor Growth in Oral Cavity Squamous Cell Carcinoma Coinjection Xenografts. Otolaryngol Head Neck Surg. 2017. PMID: 29232177. doi:10.1177/0194599817746934

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。